Literature DB >> 22213679

Efficient gene delivery to mesenchymal stem cells by an ethylenediamine-modified polysaccharide from mulberry leaves.

Wen-Wen Deng1, Xia Cao, Miao Wang, Yan Yang, Wei-Yan Su, Ya-Wei Wei, Zhen Ou-Yang, Jiang-Nan Yu, Xi-Ming Xu.   

Abstract

This study investigates the use of a natural polysaccharide isolated from mulberry leaves as a nonviral gene vector. Ethylenediamine is chemically grafted to the backbone of a polysaccharide from mulberry leaves (MPS) to acquire nucleic acid binding affinity. A particle-size observation indicates that the cationic mulberry leaf polysaccharide (CMPS) can efficiently combine with plasmid transforming growth factor β1 (TGF-β1) to form nanoscaled particles. In addition, the electrophoresis assay indicates a retarded plasmid migration when the CMPS/pTGF-β1 weight ratio is increased to 30:1. The in vitro cell transfection experiment is performed based on bone marrow mesenchymal stem cells (MSCs) derived from rat femurs and tibias, and the findings reveal that the complex with a CMPS/pTGF-β1 weight ratio of 50:1 exhibits the highest cell transfection effect, which is significantly higher than that of branched poly(ethyleneimine) (PEI) (25 kDa; p = 0.001, Student's t-test) and slightly higher than Lipofectamine 2000. Moreover, the cytotoxicity assay also demonstrates that all of these tested complexes and the plasmid TGF-β1 are nontoxic to mesenchymal stem cells (MSCs). The results of the living cell imaging confirm that more of the CMPS/plasmid TGF-β1 nanoparticles can be taken up and at a faster rate by the MSCs than by the positive control Lipofectamine 2000; these data are consistent with the transfection efficiency data. Together, these results suggest that the CMPS/pTGF-β1 nanoparticle can potentially be developed into a promising alternative for the transfer of therapeutic genes into cells.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22213679     DOI: 10.1002/smll.201101554

Source DB:  PubMed          Journal:  Small        ISSN: 1613-6810            Impact factor:   13.281


  6 in total

Review 1.  Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseases.

Authors:  Robert D Wyse; Gary L Dunbar; Julien Rossignol
Journal:  Int J Mol Sci       Date:  2014-01-23       Impact factor: 5.923

2.  Structural characterization and hypolipidemic activities of purified stigma maydis polysaccharides.

Authors:  Wenwen Deng; Xia Yang; Yuan Zhu; Jiangnan Yu; Ximing Xu
Journal:  Food Sci Nutr       Date:  2019-07-03       Impact factor: 2.863

3.  Highly Efficient MicroRNA Delivery Using Functionalized Carbon Dots for Enhanced Conversion of Fibroblasts to Cardiomyocytes.

Authors:  Lei Yang; Song Xue; Mingjun Du; Feng Lian
Journal:  Int J Nanomedicine       Date:  2021-06-01

Review 4.  Nanoparticles and their potential for application in bone.

Authors:  Andrea Tautzenberger; Anna Kovtun; Anita Ignatius
Journal:  Int J Nanomedicine       Date:  2012-08-17

5.  Efficient gene delivery to human umbilical cord mesenchymal stem cells by cationized Porphyra yezoensis polysaccharide nanoparticles.

Authors:  Qingtong Yu; Jin Cao; Baoding Chen; Wenwen Deng; Xia Cao; Jingjing Chen; Yan Wang; Shicheng Wang; Jiangnan Yu; Ximing Xu; Xiangdong Gao
Journal:  Int J Nanomedicine       Date:  2015-11-18

6.  Spermine-modified Antheraea pernyi silk fibroin as a gene delivery carrier.

Authors:  Yanni Yu; Yongpei Hu; Xiufang Li; Yu Liu; Mingzhong Li; Jicheng Yang; Weihua Sheng
Journal:  Int J Nanomedicine       Date:  2016-03-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.